HHS, vac­cine mak­ers prep for first-ever three-vac­cine avail­abil­i­ty with Covid, flu and RSV ahead of peak vi­ral sea­son

Last fall’s virus triple­dem­ic is giv­ing way to this year’s three-vac­cine sea­son. And the De­part­ment of Health and Hu­man Ser­vices says it is pulling out all the stops to make sure as many Amer­i­cans who need them get Covid-19, flu and RSV im­mu­niza­tions this fall.

Mean­while, phar­ma vac­cine mak­ers are plot­ting their own mar­ket­ing and com­mu­ni­ca­tions strate­gies around Covid vac­cines.

A CDC of­fi­cial said the US is in its “strongest po­si­tion yet” with the vac­cines against the trio of virus­es that caus­es the ma­jor­i­ty of hos­pi­tal­iza­tions in the fall and win­ter, along with broad­er pro­tec­tive im­mu­ni­ty and test avail­abil­i­ty. The agency es­ti­mat­ed that 97% of peo­ple in the US aged 16 and old­er have Covid-19 pro­tec­tive im­mu­ni­ty through vac­ci­na­tion, in­fec­tion or both, but added that peo­ple still need up­dat­ed vac­cines for pro­tec­tion against new vari­ants, in­clud­ing the now-dom­i­nant strain EG.5 and al­so FL.1.5.1.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER